X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (428) 428
Publication (28) 28
Book / eBook (5) 5
Book Review (5) 5
Book Chapter (1) 1
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rheumatoid arthritis (270) 270
humans (258) 258
rheumatology (191) 191
arthritis, rheumatoid - drug therapy (166) 166
index medicus (157) 157
female (155) 155
male (152) 152
antirheumatic agents - therapeutic use (150) 150
disease-modifying anti-rheumatic drugs (141) 141
middle aged (125) 125
methotrexate (104) 104
arthritis (95) 95
adult (92) 92
treatment outcome (87) 87
aged (81) 81
rheumatoid factor (77) 77
antirheumatic agents (71) 71
disease modifying anti-rheumatic drugs (71) 71
double-blind (55) 55
therapy (49) 49
antirheumatic agents - adverse effects (48) 48
medicine & public health (45) 45
pharmacology & pharmacy (45) 45
severity of illness index (45) 45
animals (43) 43
antirheumatic agents - administration & dosage (43) 43
drug therapy (43) 43
drug therapy, combination (43) 43
time factors (41) 41
modifying antirheumatic drugs (39) 39
anti-rheumatic drugs (36) 36
arthritis, rheumatoid - diagnosis (36) 36
drugs (34) 34
rheumatoid-arthritis (34) 34
risk factors (34) 34
analysis (33) 33
care and treatment (33) 33
methotrexate - therapeutic use (33) 33
tumor necrosis factor-alpha - antagonists & inhibitors (33) 33
anti-rheumatic agents (32) 32
etanercept (32) 32
immunology (32) 32
infliximab (32) 32
biological products - therapeutic use (30) 30
efficacy (30) 30
retrospective studies (28) 28
internal medicine (27) 27
recommendations (27) 27
remission (27) 27
abridged index medicus (26) 26
antirheumatic agents - pharmacology (26) 26
biologics (26) 26
medical research (26) 26
medicine, experimental (26) 26
medicine, general & internal (26) 26
disease (25) 25
prospective studies (25) 25
adolescent (24) 24
adalimumab (23) 23
arthritis, rheumatoid - immunology (23) 23
disease-activity (23) 23
arthritis, rheumatoid - physiopathology (22) 22
combination therapy (22) 22
management (22) 22
risk (22) 22
safety (22) 22
aged, 80 and over (21) 21
arthritis, rheumatoid - epidemiology (21) 21
follow-up studies (21) 21
inadequate response (21) 21
anti-inflammatory agents, non-steroidal - therapeutic use (20) 20
inflammation (20) 20
disease progression (19) 19
infection (19) 19
medicine (19) 19
registries (19) 19
monoclonal-antibody (18) 18
patients (18) 18
rheumatic diseases (18) 18
young adult (18) 18
disease-modifying anti-rheumatic drug (17) 17
drug administration schedule (17) 17
medicine, research & experimental (17) 17
prognosis (17) 17
remission induction (17) 17
american-college (16) 16
anti-inflammatory agents - therapeutic use (16) 16
anti-rheumatic drug (16) 16
antirheumatic drugs (16) 16
comorbidity (16) 16
corticosteroids (16) 16
psoriatic arthritis (16) 16
rats (16) 16
surveys and questionnaires (16) 16
arthritis, psoriatic - drug therapy (15) 15
arthritis, rheumatoid - complications (15) 15
cross-sectional studies (15) 15
health aspects (15) 15
juvenile idiopathic arthritis (15) 15
mice (15) 15
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (386) 386
Japanese (37) 37
Chinese (7) 7
German (7) 7
Korean (4) 4
Russian (4) 4
Polish (2) 2
Spanish (2) 2
French (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and Experimental Rheumatology, ISSN 0392-856X, 2016, Volume 34, Issue 4, pp. 698 - 705
Biological drugs and their originated biosimilars are large, highly complex molecules derived from living cells or organisms. Traditional medicines, by... 
Inflammatory bowel disease | Anti-rheumatic agents | Rheumatoid arthritis | Biosimilar pharmaceuticals | CT-P13 | Therapeutic equivalence | Ankylosing spondylitis | therapeutic equivalence | QUALITY | EFFICACY | biosimilar pharmaceuticals | anti-rheumatic agents | SAFETY | ankylosing spondylitis | ULCERATIVE-COLITIS | RHEUMATOLOGY | rheumatoid arthritis | inflammatory bowel disease | CROHN DISEASE | INFLIXIMAB | COMPARABILITY | Rheumatic Diseases - drug therapy | Humans | Inflammatory Bowel Diseases - immunology | Antibodies, Monoclonal - adverse effects | Inflammatory Bowel Diseases - diagnosis | Antibodies, Monoclonal - therapeutic use | Drugs, Generic - therapeutic use | Anti-Inflammatory Agents - adverse effects | Patient Safety | Anti-Inflammatory Agents - therapeutic use | Antirheumatic Agents - adverse effects | Biosimilar Pharmaceuticals - pharmacokinetics | Anti-Inflammatory Agents - pharmacokinetics | Drug Evaluation, Preclinical | Gastrointestinal Agents - pharmacokinetics | Gastrointestinal Agents - standards | Drugs, Generic - standards | Antirheumatic Agents - therapeutic use | Quality Control | Rheumatic Diseases - immunology | Inflammatory Bowel Diseases - drug therapy | Biosimilar Pharmaceuticals - therapeutic use | Risk Assessment | Antirheumatic Agents - standards | Biosimilar Pharmaceuticals - standards | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Rheumatic Diseases - diagnosis | Patents as Topic | Anti-Inflammatory Agents - standards | Biosimilar Pharmaceuticals - adverse effects | Drugs, Generic - adverse effects | Animals | Drug Approval - methods | Gastrointestinal Agents - therapeutic use | Antirheumatic Agents - pharmacokinetics | Gastrointestinal Agents - adverse effects | Therapeutic Equivalency
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 07/2015, Volume 23, Issue 13, pp. 3059 - 3080
Osteoarthritis and rheumatoid arthritis are the two most common types of arthritis. Cartilage breakdown is a key feature of both diseases which contributes to... 
Disease-modifying anti-rheumatic drugs | Cyclooxygenase | Kinase | Natural products | Rheumatoid arthritis | Methotrexate | Osteoarthritis | Non-steroidal anti-inflammatory drugs | Nutraceuticals | COLLAGEN-INDUCED ARTHRITIS | MODIFYING ANTIRHEUMATIC DRUGS | CHEMISTRY, MEDICINAL | ACTIVE RHEUMATOID-ARTHRITIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | METHOTREXATE DERIVATIVES BEARING | CHEMISTRY, ORGANIC | RANDOMIZED CONTROLLED-TRIAL | CONTROLLED CLINICAL-TRIAL | BOSWELLIA-SERRATA EXTRACT | MATRIX METALLOPROTEINASE-13 INHIBITORS | PLACEBO-CONTROLLED TRIAL | NF-KAPPA-B | Glucocorticoids - chemical synthesis | Glucocorticoids - therapeutic use | Analgesics, Opioid - chemical synthesis | Cartilage - pathology | Humans | Drugs, Investigational - therapeutic use | Cartilage - drug effects | Methotrexate - therapeutic use | Osteoarthritis - drug therapy | Joints - physiopathology | Osteoarthritis - physiopathology | Methotrexate - chemical synthesis | Arthritis, Rheumatoid - drug therapy | Antirheumatic Agents - chemical synthesis | Osteoarthritis - pathology | Anti-Inflammatory Agents, Non-Steroidal - chemical synthesis | Arthritis, Rheumatoid - physiopathology | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Drugs, Investigational - chemical synthesis | Pain - prevention & control | Joints - drug effects | Analgesics, Opioid - therapeutic use | Joints - pathology | Cartilage - physiopathology | Pain - pathology | Biological Products - isolation & purification | Arthritis, Rheumatoid - pathology | Biological Products - chemistry | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pain - physiopathology | Antiarthritic agents | Arthritis | Rheumatoid factor | Corticosteroids | Fluocinolone acetonide | Functional foods | Opioids | Development and progression
Journal Article
2005, Progress in inflammation research, ISBN 3764365951, xiii, 343
This book gives a comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of... 
Chemotherapy | Rheumatoid arthritis | Antirheumatic agents | Clinical & internal medicine | Medicine & Public Health | Medicine/Public Health, general
Book
Rheumatology (United Kingdom), ISSN 1462-0324, 07/2015, Volume 54, Issue 7, pp. 1170 - 1176
Objective. The aim of this study was to carry out a safety evaluation of biologic agents in patients with JIA and associated uveitis. Methods. In three... 
Anti-rheumatic agent | Anti-TNF | Disease-modifying anti-rheumatic drug | Adverse drug event | Biologic therapy | Juvenile idiopathic arthritis | adverse drug event | disease-modifying anti-rheumatic drug | biologic therapy | juvenile idiopathic arthritis | anti-rheumatic agent | anti-TNF | RHEUMATOID-ARTHRITIS | EFFICACY | SAFETY | METHOTREXATE | OPEN-LABEL | RHEUMATOLOGY | COMBINATION | ETANERCEPT | INFLIXIMAB | EPIDEMIOLOGY | Follow-Up Studies | Humans | Antibodies, Monoclonal - adverse effects | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Infant | Male | Alanine Transaminase - blood | Opportunistic Infections - chemically induced | Arthritis, Juvenile - drug therapy | Incidence | Receptors, Tumor Necrosis Factor - therapeutic use | Young Adult | Etanercept | Infliximab | Uveitis - epidemiology | Female | Retrospective Studies | Child | Headache - chemically induced | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Opportunistic Infections - epidemiology | Immunoglobulin G - therapeutic use | Arthritis, Juvenile - blood | Immunoglobulin G - adverse effects | Biological Factors - therapeutic use | Psoriasis - epidemiology | Headache - epidemiology | Psoriasis - chemically induced | Adolescent | Arthritis, Juvenile - complications | Patient Compliance | Adalimumab | Biological Factors - adverse effects | Longitudinal Studies | Uveitis - chemically induced | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Clinical and experimental rheumatology, ISSN 0392-856X, 2015, Volume 33, Issue 2, pp. 216 - 224
Journal Article
Journal Article
Acta Reumatológica Portuguesa, ISSN 0303-464X, 01/2019, Volume 2019, Issue 1, pp. 57 - 64
Objectives: To assess the discontinuation of first-line biological treatment and to evaluate the reasons and predictors thereof in patients with rheumatoid... 
rheumatoid arhtritis | anti-tumor necrosis factor-alpha therapy | DMARD | biologic disease-modifying anti-rheumatic drugs (bDMARDs)
Journal Article
Journal Article